Trials / Conditions / Cerebrotendinous Xanthomatoses
Cerebrotendinous Xanthomatoses
6 registered clinical trials studyying Cerebrotendinous Xanthomatoses — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | A Study of Chenodeoxycholic Acid (CDCA) in Newly Diagnosed Participants With Cerebrotendinous Xanthomatosis (C NCT06260748 | Leadiant Biosciences, Inc. | Phase 3 |
| Completed | Bioequivalence Study to Compare Chenodeoxycholic Acid Capsules (250mg Chenodeoxycholic Acid) Versus Chenodeoxy NCT06180057 | Humanis Saglık Anonim Sirketi | Phase 1 |
| Enrolling By Invitation | Early Check: Expanded Screening in Newborns NCT03655223 | RTI International | — |
| Completed | LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies NCT02699190 | Children's Hospital of Philadelphia | — |
| Recruiting | The Myelin Disorders Biorepository Project NCT03047369 | Children's Hospital of Philadelphia | — |
| Completed | Safety and Efficacy of CDCA in CTX Chenodeoxycholic Acid (CDCA) in Patients Affected by Cerebrotendinous Xanth NCT05499026 | Leadiant Biosciences Ltd. | — |